Contract win thanks to global demand for early diagnosis for critical illnesses
Radiation and bio-detection company, Kromek Group, has secured an initial order for its CZT-based detector modules from a new OEM customer, which is an established player in Asia’s medical imaging sector.
The contract is worth a total of $1.425m/£1.143m and is in one of the group’s key target markets of single photon emission computed tomography (SPECT).
Kromek’s CZT-based detector modules will be used in the customer’s next generation SPECT systems in niche applications. Delivery and revenue recognition will be in the current financial year.
Arnab Basu, CEO of Huddersfield-based Kromek, said: “This order, from a new OEM customer, is another demonstration of the robust demand for our innovative CZT-based medical imaging solutions in SPECT applications.
“This order from a new customer in Asia underscores the requirement of CZT-based detectors due to demand globally for early diagnosis of critical illnesses leading to better patient outcomes.
“This initial order improves the group’s visibility over full year revenues, and as such the Board is confident in delivering further significant growth in the year ending 30 April 2024.”